Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Former FDA Cosmetics Director Weighs In On Senator Hatch's Draft FCSMA

Nov 08 2017

• By Ryan Nelson

Related Content

PCPSA's 'No Harm' Standard Would Set High Bar For FDA Ingredient Review

Apr 14 2016

FDA’s Candid Overview Of Cosmetics Regime Signals Support For Reform Bill

Oct 14 2016

FDA Seeks Info From Injured WEN Users, Docs As Investigation Continues

Jul 19 2016

Cosmetic Ingredient Use Under Feinstein Bill; Where Does CIR Come In?

Apr 22 2015

Senate HELP Hearing Focuses On WEN, High-Profile Cosmetic Safety Issues

Sep 23 2016

Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners

May 12 2017

EWG Seeks Court-Ordered Deadlines For FDA Action On Hazardous Hair Smoothers

May 22 2017

Hatch's Cosmetics Bill Trades Recall Authority For New 'Adulterated' Language

Nov 08 2017

Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform

Oct 26 2017

ICMAD Stands By House Cosmetics Bill, But May Be Ready To Negotiate

Nov 01 2017

Jan Marini Focused On Damage Control Following FDA Seizure Of Eyelash Item

Nov 26 2007

Additional Topics

United States Legislation Legal Issues Cosmetics Consumer

More from Legislation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window